BIOMARKERS FOR ASSESSING PERIPHERAL NEUROPATHY RESPONSE TO TREATMENT WITH A PROTEASOME INHIBITOR

摘要

The present invention provides methods for identifying patients at increased risk of developing an adverse neurological event in response to a cancer treatment. Methods also include modifying the treatment regimen of said patent dependent on the presence or absence of biomarkers in the patient.